Literature DB >> 36123407

Risk factors for intraocular pressure elevation following Descemet membrane endothelial keratoplasty in Asian patients.

Yasutsugu Ida1,2, Toshiki Shimizu2,3, Tsubasa Kuroki1,2, Yuki Mizuki1,2, Masato Takeda1,2, Nobuhisa Mizuki2, Satoru Yamagami3, Takahiko Hayashi4,5.   

Abstract

PURPOSE: To investigate risk factors for increased intraocular pressure (IOP) after Descemet membrane endothelial keratoplasty (DMEK) in Asian patients.
METHODS: Data from January 2015 to February 2021 were obtained from our prospective database. IOP elevation after DMEK was defined as IOP ≥ 22 mmHg or an increase in IOP of ≥ 10 mmHg from baseline. In addition, we examined maximum IOP. Using iCare, we measured IOP 1, 2, 3, and 6 months after DMEK, and every 6 months thereafter. Logistic regression and linear regression were performed to find factors predictive of IOP elevation and maximum IOP, respectively, based on the results of univariate analysis.
RESULTS: We enrolled 90 eyes (mean patient age, 74.9 ± 7.5 years; mean follow-up duration, 25.6 ± 9.9 months) that underwent DMEK. IOP elevation was present in 19 eyes (21%). IOP increased from 12.6 ± 3.9 mmHg preoperatively to a postoperative maximum of 17.0 ± 5.5 mmHg up to 36 months after DMEK (p < 0.0001). In univariate logistic regression analysis for IOP elevation, only one variable, pseudoexfoliation syndrome (PEX) and preexisting glaucoma, was significant (p < 0.05). Preexisting glaucoma without PEX (OR, 19.33; 95% CI, 4.75-93.46), PEX without glaucoma (OR, 7.25; 95% CI, 1.20-41.63), and PEX glaucoma (OR, 58.00; 95% CI, 6.78-1298.29) were associated with higher risk of IOP elevation.
CONCLUSIONS: In this cohort, the eyes of patients with PEX and preexisting glaucoma were found to be prone to IOP elevation after DMEK.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Betamethasone; Descemet membrane endothelial keratoplasty; Fluorometholone; Intraocular pressure elevation; Preexisting glaucoma without pseudoexfoliation syndrome; Pseudoexfoliation syndrome; Steroid eye drop

Year:  2022        PMID: 36123407     DOI: 10.1007/s00417-022-05835-y

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.535


  2 in total

Review 1.  Descemet's membrane endothelial keratoplasty (DMEK) versus Descemet's stripping automated endothelial keratoplasty (DSAEK) for corneal endothelial failure.

Authors:  Alastair J Stuart; Vito Romano; Gianni Virgili; Alex J Shortt
Journal:  Cochrane Database Syst Rev       Date:  2018-06-25

Review 2.  Challenges in the complex management of post-keratoplasty glaucoma.

Authors:  Lisa-Marie Anders; Zisis Gatzioufas; Matthias C Grieshaber
Journal:  Ther Adv Ophthalmol       Date:  2021-07-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.